{"entity":{"type":"insider","cik":"0001486519","url":"/insider/0001486519","json_url":"/insider/0001486519.json","name":"Johnston David Brannon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":17,"first":"2011-08-03","last":"2018-06-08","span_basis":"filed_date"},"name_variants":[{"name":"Johnston David Brannon","source":"filing","n_filings":17,"first_seen":"2011-08-03","last_seen":"2018-06-08"}],"transactions":[{"id":6463495,"accession":"0001179110-18-008295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-008295","line_url":"/filing/0001179110-18-008295#line-2","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.02,"price_display":"11.02","price_state":"stated","total_value":110200.0,"total_display":"110,200.00","total_whole":"110,200","shares_owned_after":180690.0,"shares_owned_after_display":"180,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-08","scope":"insider"},{"id":6067906,"accession":"0001179110-18-004419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-004419","line_url":"/filing/0001179110-18-004419#line-2","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.53,"price_display":"11.53","price_state":"stated","total_value":115300.0,"total_display":"115,300.00","total_whole":"115,300","shares_owned_after":180690.0,"shares_owned_after_display":"180,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-16","scope":"insider"},{"id":6067743,"accession":"0001179110-18-002674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-002674","line_url":"/filing/0001179110-18-002674#line-1","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21060.0,"shares_display":"21,060","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":228922.2,"total_display":"228,922.20","total_whole":"228,922","shares_owned_after":180690.0,"shares_owned_after_display":"180,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-21","filed_date":"2018-02-23","scope":"insider"},{"id":2402671,"accession":"0001179110-16-031100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-031100","line_url":"/filing/0001179110-16-031100#line-1","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.6981,"price_display":"1.70","price_state":"stated","total_value":16981.0,"total_display":"16,981.00","total_whole":"16,981","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-02","filed_date":"2016-11-03","scope":"insider"},{"id":8441290,"accession":"0001104659-15-066207","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-066207","line_url":"/filing/0001104659-15-066207#line-2","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-17","filed_date":"2015-09-21","scope":"insider"},{"id":8862932,"accession":"0001179110-15-011645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-011645","line_url":"/filing/0001179110-15-011645#line-2","is_derivative":false,"issuer_cik":"0000855654","issuer_name":"IMMUNOGEN INC","issuer_ticker":"IMGN","issuer_name_source":null,"issuer_url":"/issuer/0000855654","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.036,"price_display":"17.04","price_state":"stated","total_value":85180.0,"total_display":"85,180.00","total_whole":"85,180","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-04","scope":"insider"},{"id":4590019,"accession":"0001181431-13-016955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-016955","line_url":"/filing/0001181431-13-016955#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1061.0,"shares_display":"1,061","price_per_share":7.3367,"price_display":"7.34","price_state":"stated","total_value":7784.2387,"total_display":"7,784.24","total_whole":"7,784","shares_owned_after":55943.0,"shares_owned_after_display":"55,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-14","scope":"insider"},{"id":5409526,"accession":"0001181431-13-005179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-005179","line_url":"/filing/0001181431-13-005179#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1150.0,"shares_display":"1,150","price_per_share":7.7711,"price_display":"7.77","price_state":"stated","total_value":8936.765,"total_display":"8,936.76","total_whole":"8,937","shares_owned_after":57004.0,"shares_owned_after_display":"57,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-28","scope":"insider"},{"id":2248300,"accession":"0001181431-12-050547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-050547","line_url":"/filing/0001181431-12-050547#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1386.0,"shares_display":"1,386","price_per_share":10.6033,"price_display":"10.60","price_state":"stated","total_value":14696.1738,"total_display":"14,696.17","total_whole":"14,696","shares_owned_after":24593.0,"shares_owned_after_display":"24,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-13","filed_date":"2012-09-14","scope":"insider"},{"id":3489890,"accession":"0001181431-12-035554","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-035554","line_url":"/filing/0001181431-12-035554#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":12.21,"price_display":"12.21","price_state":"stated","total_value":183150.0,"total_display":"183,150.00","total_whole":"183,150","shares_owned_after":25154.0,"shares_owned_after_display":"25,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-06","filed_date":"2012-06-08","scope":"insider"},{"id":2350370,"accession":"0001181431-12-004441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-004441","line_url":"/filing/0001181431-12-004441#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1107.0,"shares_display":"1,107","price_per_share":13.3658,"price_display":"13.37","price_state":"stated","total_value":14795.9406,"total_display":"14,795.94","total_whole":"14,796","shares_owned_after":5454.0,"shares_owned_after_display":"5,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-26","filed_date":"2012-01-30","scope":"insider"},{"id":9061915,"accession":"0001181431-11-058766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-058766","line_url":"/filing/0001181431-11-058766#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.737,"price_display":"16.74","price_state":"stated","total_value":16737.0,"total_display":"16,737.00","total_whole":"16,737","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-05","scope":"insider"},{"id":9141609,"accession":"0001181431-11-054319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-054319","line_url":"/filing/0001181431-11-054319#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":15.439,"price_display":"15.44","price_state":"stated","total_value":30878.0,"total_display":"30,878.00","total_whole":"30,878","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-02","scope":"insider"},{"id":9024827,"accession":"0001181431-11-051523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-051523","line_url":"/filing/0001181431-11-051523#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":15.4337,"price_display":"15.43","price_state":"stated","total_value":30867.4,"total_display":"30,867.40","total_whole":"30,867","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-03","filed_date":"2011-10-04","scope":"insider"},{"id":8925477,"accession":"0001181431-11-048283","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-048283","line_url":"/filing/0001181431-11-048283#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.8735,"price_display":"16.87","price_state":"stated","total_value":33747.0,"total_display":"33,747.00","total_whole":"33,747","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-07","scope":"insider"},{"id":9004385,"accession":"0001181431-11-046988","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-046988","line_url":"/filing/0001181431-11-046988#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1906.0,"shares_display":"1,906","price_per_share":16.43,"price_display":"16.43","price_state":"stated","total_value":31315.58,"total_display":"31,315.58","total_whole":"31,316","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-24","filed_date":"2011-08-25","scope":"insider"},{"id":9015211,"accession":"0001181431-11-043703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-043703","line_url":"/filing/0001181431-11-043703#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001486519","owner_name":"Johnston David Brannon","owner_display_name":"Johnston David Brannon","owner_url":"/insider/0001486519","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.29,"price_display":"19.29","price_state":"stated","total_value":57870.0,"total_display":"57,870.00","total_whole":"57,870","shares_owned_after":7906.0,"shares_owned_after_display":"7,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-01","filed_date":"2011-08-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000855654","name":"IMMUNOGEN INC","url":"/issuer/0000855654","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2015-08-04","last_seen":"2018-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2011-08-03","last_seen":"2013-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001486519","retrieved_at":"2026-08-24T05:58:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}